Dossier · DOCU · Dormant
DOCU · DocuSign, Inc. · Stock research
Last analysed ·
Current thesis
Legacy e-signature base re-wrapped as AI agreement management: IAM went 10.8%→12.6% of ARR in a quarter and is guided to ~18% by 2027-01-31, while total growth is still guided to decelerate to ~8%. The 2026-09-03 Q2 print is now confirmed and is the binary; at $62.00 the stock trades above the $59.33 22-analyst average target.
Kill line
A weekly close below $54 returns price into the $50–$54 band where post-Q1 targets were reset on 2026-06-05 and erases the summer advance; secondarily, a Q2 FY27 print on 2026-09-03 that leaves IAM near the 12.6%-of-ARR level or trims FY27 ARR growth below the 8.25% floor.
Pick status
Open commitment catalyst in 8dscored if the kill line above fires How this is scored →Latest analysis and events for DOCU —
As of 22 August 2026, the latest FrontierPicks analysis for DocuSign, Inc. (DOCU): Legacy e-signature base re-wrapped as AI agreement management: IAM went 10.8%→12.6% of ARR in a quarter and is guided to ~18% by 2027-01-31, while total growth is still guided to decelerate to ~8%. The 2026-09-03 Q2 print is now confirmed and is the binary; at $62.00 the stock trades above the $59.33 22-analyst average target.
Kill line: A weekly close below $54 returns price into the $50–$54 band where post-Q1 targets were reset on 2026-06-05 and erases the summer advance; secondarily, a Q2 FY27 print on 2026-09-03 that leaves IAM near the 12.6%-of-ARR level or trims FY27 ARR growth below the 8.25% floor.
Next dated event on file: — catalyst in 8d.
Current Thesis
The leg on offer is a legacy-pivot re-rate: a high-single-digit-growth e-signature franchise being repriced on the mix shift into Intelligent Agreement Management (IAM), the AI-native agreement layer. IAM was 12.6% of total ARR at 2026-04-30 versus 10.8% at 2026-01-31, with management guiding to roughly 18% of ARR and over $600M of IAM ARR by fiscal year-end (2027-01-31). Two things changed since the last update. On 2026-08-13 the company fixed the date of the quarter's only scheduled binary — Q2 FY2027 results after the US close on Thursday 2026-09-03, call at 5:00 p.m. ET — so the "~September, est." placeholder is now a hard date. And price kept grinding: the 2026-08-21 close of $62.00 sits 27.1% under the 52-week high of $85.01 after a three-month advance of 25.2%, which puts it above the 22-analyst average target of $59.33 (stockanalysis.com, retrieved 2026-08-22). The setup into the print is a stock that has caught the sell-side average with the disclosed growth rate still guided to decelerate.
Bullish and bearish views on DocuSign, Inc.
The model's bull view on DocuSign, Inc. (DOCU), in brief: IAM mix moved 180bp in one quarter — 10.8% of ARR at 2026-01-31 to 12.6% at 2026-04-30 — with ~40,000 customers described as investing in the platform (Q1 FY27 release, 2026-06-04). The bear view: The pivot still has not moved the top line. Both cases follow in full.
Bull Case
- IAM mix moved 180bp in one quarter — 10.8% of ARR at 2026-01-31 to 12.6% at 2026-04-30 — with ~40,000 customers described as investing in the platform (Q1 FY27 release, 2026-06-04).
- Citizens reiterated a Market Outperform with an $86 target on 2026-08-18, the highest dated target in the recent set and roughly the level of the 52-week high.
- Cash generation is not the disputed part: Q1 FY27 operating cash flow $321.7M, free cash flow $289.4M, cash and investments $1.0B.
- Repurchases of $317.5M in Q1 FY27 exceeded that quarter's free cash flow — the company bought more stock than it generated in cash through the drawdown.
- Profitability holds on the reported line, not only the adjusted one: Q1 FY27 GAAP net income $78.2M, GAAP diluted EPS $0.40, against non-GAAP net income $214.9M.
- The FY27 non-GAAP operating margin guide was raised on 2026-06-04 to 30.5%–31.0%.
- Sponsor interest in decelerating, cash-generative enterprise software became a live public data point on 2026-08-13, when Reuters reported Silver Lake in talks to take Workday private (valuation figures reported vary — around $43B per Benzinga and The Next Web, "$50bn-plus" per Private Equity Wire).
Bear Case
- The pivot still has not moved the top line. Q1 FY27 revenue was $830.2M, +9% YoY, including roughly 1.6 points of FX benefit; FY27 revenue is guided to $3.490–3.502B, about +9% at the midpoint, with ARR growth of 8.25%–8.75%.
- Q2 FY27 is guided to $865–869M, roughly +8% YoY at the midpoint, and non-GAAP operating margin of 29.7%–30.2%, below the 32.0% printed in Q1.
- At the ~18% fiscal-year-end IAM target, more than four-fifths of ARR is still the older seat-and-envelope base.
- Price has overtaken the coverage. The consensus rating is Hold with an average target of $59.33 across 22 analysts (retrieved 2026-08-22), below the 2026-08-21 close of $62.00. On 2026-06-05 BTIG cut its target to $60 while keeping a Buy, and Wedbush's stood at $58 with a Hold.
- The market's last reaction to a beat was negative: Zacks flagged a 7.2% decline in the sessions after the 2026-06-04 Q1 report.
- The competitive overhang keeps getting funded in private markets — The Information reported on 2026-08-07 that legal-AI vendor Harvey was in talks to raise at a $15.5B valuation, which is the "agents absorb contract workflow" argument expressed as a bid.
Setup & Price Structure
The 2026-08-21 close was $62.00, with RSI(14) at 65.9; two weeks earlier, on 2026-08-07, the close was $60.26 with RSI(14) at 64.5. Price advanced and momentum barely moved, which is a grind rather than an impulse. The shares are 27.1% below the 52-week high of $85.01 and up 25.2% over three months, so this remains a recovery leg off a deep reset that has retraced roughly a third of the way back toward the old high.
The narrative is maturing. The dating: IAM has been the headline disclosed metric across multiple quarters, the aggregate rating is Hold, and the fresh August headlines are second-order — a peer take-private report on 2026-08-13 and a single reiteration on 2026-08-18 — rather than new attention on this company's own narrative. It is still working (up 25.2% over three months) while new sell-side flow is thin.
Crowding and positioning observables, stated as observables: price sits above the 22-analyst average target of $59.33 as of 2026-08-22; the most recent dated revision cluster (2026-06-05) left BTIG at $60 and Wedbush at $58, both below the last close; the outlier is Citizens at $86 (2026-08-18); RSI(14) 65.9 is elevated without being extended; the earnings print lands 13 days after the reference close; and the filings feed for the trailing window shows no insider transactions and no equity issuance. The company's own repurchase running above free cash flow in Q1 FY27 is the opposite of insiders distributing into strength, and it is the single largest identified marginal buyer in the disclosures.
Catalyst Calendar (next 30 days)
- 2026-09-03 — Q2 FY2027 results, quarter ended 2026-07-31, released after the US close; conference call 5:00 p.m. ET (confirmed by company announcement 2026-08-13). Tests revenue against the $865–869M guide, non-GAAP operating margin against 29.7%–30.2%, and IAM as a share of total ARR against the ~18% full-year path. Any change to the 8.25%–8.75% FY27 ARR growth range resets the valuation debate.
- ~2026-09-04 (est.) — the post-print sell-side revision window. Precedent: on 2026-06-05, the morning after the Q1 report, at least four firms re-anchored targets in a $50–$60 band. Whether the September revisions clear the last close is the cleanest read on whether the recovery leg has coverage behind it.
Elapsed catalysts
- Undated, live — resolution of the Silver Lake/Workday take-private talks reported 2026-08-13. A signed deal would put a dated multiple on a large, decelerating, cash-generative software franchise; abandoned talks remove that comparison. (passed 13d ago)
What Would Change Our Mind
Giving that back would say the mix-shift story is being repriced rather than absorbed: a weekly close below $54 returns price inside the $50–$54 band anchored by the 2026-06-05 revisions and erases most of the three-month move.
Second, the 2026-09-03 print is the item that can break the fundamental leg without touching that level immediately. Revenue at or below the $865M low end, an FY27 ARR growth guide trimmed under the 8.25% floor, or IAM reported flat-to-marginally-higher versus 12.6% of ARR would each remove the accelerating disclosed metric the whole re-rate depends on. A print that clears the guide but produces no target raises above the last close would leave the same problem in slower motion.
Third, the life-cycle label. If September coverage arrives as mainstream "AI turnaround" framing while the ARR growth range stays at 8-and-change, the label moves toward saturated and the thin-new-bid problem becomes the read.
Correlation Notes
- Take-private complex. The 2026-08-13 Workday report re-opened the sponsor bid for large-cap software with decelerating growth and heavy free cash flow. DocuSign screens on the same axes — $289.4M quarterly free cash flow, ~9% growth, $1.0B cash — so headlines on that deal are likely to move the name for reasons unrelated to IAM.
- AI-agent disruption basket. Moves inversely to funding news for contract/legal AI (the reported Harvey $15.5B round, 2026-08-07). The same event is a bull datapoint for the category and a bear datapoint for seat-based agreement pricing.
- Enterprise SaaS beta. The stock trades with the software complex around rate and capex-digestion headlines; the 25.2% three-month move is not idiosyncratic to a company-specific catalyst, since no company-specific catalyst has occurred since 2026-06-04.
- Fiscal calendar offset. Reporting lands after the peak of calendar-Q2 season, so DocuSign prints into a comparison set already established by earlier SaaS reports — the read-through runs from peers to DocuSign, rarely the other way.
Notes
- Fiscal year ends January 31 — 'fiscal 2027' is the year ending 2027-01-31, so quarter labels run about eleven months ahead of the calendar.
- Large GAAP/non-GAAP gap from stock-based compensation: Q1 FY27 GAAP net income $78.2M versus non-GAAP $214.9M. Multiples differ sharply by which line is used.
- IAM percentage-of-ARR is a company-defined metric with no audited cross-vendor comparable; it is disclosed quarterly and is how management frames the pivot.
- Results are released after the US close, historically on the first Thursday of March, June, September and December, with the date confirmed roughly two to three weeks prior.
Related · shared themes
OKTA
Okta, Inc.
Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme accelerating, this leg maturing; open risk is paying up for a stretched 52-week-high tape.
HNGE
Hinge Health, Inc.
Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.
HPE
Hewlett Packard Enterprise Company
The one green close failed: 2026-08-24 closed $52.43, undercutting the 08-20 low close of $52.89 and marking seven of eight sessions lower off the 2026-08-13 high of $59.82, with no dated HPE news since 2026-08-19. The 2026-09-02 Q3 print is the binary — screens carry ~$0.93–0.94 EPS on ~$11.97B against a $0.88–0.93 / $11.5–12.1B guide. The narrative is saturated.
SNX
TD SYNNEX Corporation
Second-order AI re-rating still unconfirmed by company data, and the tape has now taken it back: the 2026-08-24 close of $243.65 leaves a three-month price change of +1.7% with RSI(14) at 27.3. The 11-analyst panel has not revised since 2026-07-22, across five external events. NVDA on 2026-08-26 re-prices the complex a month before TD SYNNEX discloses anything.
See also · stocks to watch